CHU-SARI study: Role of respiratory viruses in adult hospitalizations for severe acute respiratory infections (SARI)

ISRCTN ISRCTN49172439
DOI https://doi.org/10.1186/ISRCTN49172439
Secondary identifying numbers N/A
Submission date
20/01/2014
Registration date
21/02/2014
Last edited
27/02/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Winter hospitalizations for severe acute respiratory infections (SARI) due to an influenza virus have been assessed at University Hospital CHU Mont-Godinne since the 2009 influenza A/H1N1 pandemic wave. All patients presenting to the Emergency Department (ED) are screened according to a SARI case definition. Nasopharyngeal swabs are collected to test for influenza. Recent studies have focused on the role of other respiratory viruses as a cause of illness and death during the winter months. The aims of the study are to assess the impact of influenza and other respiratory viruses during the 2013-2014 winter season, along with the use of internal diagnostic methods in virology.

Who can participate ?
Adult patients matching with the SARI case definition (fever > 38°C or history of fever associated with cough and/or dyspnea (shortness of breath), and requiring hospitalization for more than 24 h), who consent for nasopharyngeal swabbing.

What does the study involve ?
SARI patients will be screened at admission. Nasopharyngeal swabbing is considered as routine practice for SARI patients hospitalized at CHU Mont-Godinne. Infection control measures (transmission-based precautions) are applied as recommended for suspected or documented respiratory viral pathogens. Medical management of patients follows recommendations regarding antiviral treatment for influenza infection, and eventual antibiotic therapy adaptation.

What are the possible benefits and risks of participating ?
The benefits for the patients are the possible initiation of an antiviral treatment for documented influenza infection, and the possible adaptation of antibiotic therapy in case of viral documented infection (influenza and/or another respiratory virus). There are no risks for patients included in the study, as nasopharyngeal swabbing is a non-invasive procedure, and all the medical interventions carried out are same as that performed in standard practice.

Where is the study run from ?
University Hospital Mont-Godinne at Yvoir (Belgium).

When is the study starting and how long is it expected to run for ?
Recruitment started in November 2013 and study will run until April 2014. Participants will be enrolled on the study up to the end of winter period, 2014.

Who is funding the study ?
Mont-Godinne Foundation, Belgium.

Who is the main contact ?
Professor Bénédicte Delaere
Mr Marc Bourgeois, marc.bourgeois@uclouvain.be

Contact information

Prof Bénédicte Delaere
Scientific

CHU Mont-Godinne (Catholic University of Louvain)
Infectious Diseases Unit
Av Dr G Therasse 1
Yvoir
5530
Belgium

Study information

Study designDescriptive observational cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeScreening
Participant information sheet Not available in web format, please contact marc.bourgeois@uclouvain.be to request a patient information sheet
Scientific titleA descriptive observational cohort study to determine the role of respiratory viruses in adult hospitalizations for severe acute respiratory infections (SARI)
Study acronymCHU-SARI
Study objectivesIt is hypothesized that winter hospitalizations for acute respiratory infections related to viral pathogens are underestimated. Influenza can lead to severe acute infection, but other respiratory viruses may also contribute to morbidity and mortality, especially in adult patients with risk factors.
Ethics approval(s)CHU Mont-Godinne Ethics Committee, 14/11/2013, ref. BUN 039201318786
Health condition(s) or problem(s) studiedInfectious diseases/Respiratory viruses/Epidemiology
InterventionScreening of SARI patients at admission
Nasopharyngeal swabbing
Multiplex rt-PCR for respiratory viruses
Collection and analysis of clinical and epidemiological data
Intervention typeOther
Primary outcome measure1. Patients positive for at least one respiratory virus
2. Patients with risk factors

All outcomes measured by prospective and retrospective review of electronic medical charts of enrolled patients (date of admission as baseline, date of discharge, and date of medical hospitalization report completed).
Secondary outcome measures1. Viral co-infections with two or more respiratory viruses
2. Bacterial co-infections
3. Epidemiology, clinical course and outcome (risk factors, length of stay, complications, intensive care admission, death)
4. Instauration of antiviral treatment following virological diagnosis
5. Adaptation of antibiotic treatment following virological diagnosis
Overall study start date15/11/2013
Completion date15/04/2014

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants250
Key inclusion criteria1. Adult (aged above 16 years)
2. New admission and within 7 days of admission
3. Fever > 38 or history of fever, cough and/or dyspnea
4. Requiring hospitalization for over 24h
5. Oral consent for nasopharyngeal swabbing
Key exclusion criteria1. Patients under 16 years of age
2. Patients already hospitalized and developing a SARI
Date of first enrolment15/11/2013
Date of final enrolment15/04/2014

Locations

Countries of recruitment

  • Belgium

Study participating centre

CHU Mont-Godinne (Catholic University of Louvain)
Yvoir
5530
Belgium

Sponsor information

Mont-Godinne Foundation (Belgium)
Charity

CHU Mont-Godinne (Catholic University of Louvain, Belgium)
Av Dr G. Therasse, 1
Yvoir
5530
Belgium

Funders

Funder type

Charity

Mont-Godinne Foundation (Belgium) (CHU Mont-Godinne, Catholic University of Louvain) (Belgium)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan